BRIEF-Abbott agrees to DOJ settlement over 2022 infant formula recall
Reuters2026/09/14 15:57Sept 14 (Reuters) - Abbott Laboratories ABT.N:
ABBOTT REACHES AGREEMENT WITH DEPARTMENT OF JUSTICE TO RESOLVE CLAIMS RELATING TO 2022 INFANT FORMULA RECALL
ABBOTT - TO PAY $385 MILLION TO RESOLVE CLAIMS; NO FINDING OF FAULT OR LIABILITY
ABBOTT: NO UNOPENED, DISTRIBUTED ABBOTT INFANT FORMULAS HAVE EVER TESTED POSITIVE FOR CRONOBACTER SAKAZAKII
Further company coverage: ABT.N
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Japan’s Katayama says will scrutinise budget requests for next fiscal year strictly going forward
British Pound drops against Japanese Yen after UK labor market data
Lippo Cikarang holds extraordinary shareholder meeting to appoint new commissioner
NYK, partners win ClassNK approval-in-principle for low-pressure liquefied CO2 carrier design
Crypto prices
More
